Annual report pursuant to Section 13 and 15(d)

Statements of Shareholders'/Members' Equity Statements of Shareholders/Members' Equity

v3.4.0.3
Statements of Shareholders'/Members' Equity Statements of Shareholders/Members' Equity - USD ($)
$ in Thousands
Total
Retained Earnings [Member]
Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Restricted Stock [Member]
Common Stock [Member]
Restricted Stock Units (RSUs) [Member]
Performance Shares [Member]
Common stock, shares outstanding, beginning of period at Mar. 31, 2013           31,307,582    
Balance, beginning of period at Mar. 31, 2013 $ 226,047 $ 24,064 $ 0 $ (1,075)   $ 203,058    
Issuance of common stock in lieu of compensation, shares             18,786 10,594
Stock-based compensation expense           2,203    
Excess tax deduction from stock options (118)         $ (118)    
Net income (loss) 25,799 25,799            
Foreign curency translation adjustment (6,724)     (6,724)        
Interest rate swap (81)              
Other 0              
Foreign provision 12,451              
Other $ 25,799     0        
Issuance of common stock in exercise of stock options, shares 18,786         566,487    
Issuance of common stock in exercise of stock options $ 3,340         $ 3,340    
Issuance of restricted stock as deferred compensation to employees and directors           17,416    
Common stock, shares outstanding, end of period at Mar. 31, 2014           31,920,865.000    
Balance, end of period at Mar. 31, 2014 250,466 49,863 0 (7,880)   $ 208,483    
Income (Loss) Attributable to Noncontrolling Interest 0              
Net income (loss) 49,386              
Issuance of common stock in lieu of compensation, shares             46,360 15,162
Stock-based compensation expense 3,295         3,295    
Excess tax deduction from stock options 1,592         $ 1,592    
Net income (loss) 49,386 49,386            
Foreign curency translation adjustment (32,667)     (32,667)        
Interest rate swap (404)     (404)        
Other (449)     (449)        
Foreign provision 13,160              
Issuance of common stock in exercise of stock options, shares           88,050    
Issuance of common stock in exercise of stock options $ 547         $ 547    
Issuance of restricted stock as deferred compensation to employees and directors 11,956       11,956      
Common stock, shares outstanding, end of period at Mar. 31, 2015 32,082,393         32,082,393.000    
Balance, end of period at Mar. 31, 2015 $ 271,766 99,249 0 (41,400)   $ 213,917    
Income (Loss) Attributable to Noncontrolling Interest 0              
Issuance of common stock in lieu of compensation, shares           18,578 69,704 22,989
Stock-based compensation expense 3,749         $ 3,749    
Excess tax deduction from stock options 92              
Repurchase of employee stock units on vesting (1,265)         $ (1,265)    
Net income (loss) 23,009 23,009            
Foreign curency translation adjustment (3,242)     (3,242)        
Interest rate swap (340)     (340)        
Other 413     (413)        
Foreign provision 8,503              
Other 413              
Non-controlling interest in acquisition 3,638   3,638          
Issuance of common stock in exercise of stock options, shares           29,056    
Issuance of common stock in exercise of stock options $ 240              
Issuance of restricted stock as deferred compensation to employees and directors           18,578    
Common stock, shares outstanding, end of period at Mar. 31, 2016 32,222,270         32,222,720.00    
Balance, end of period at Mar. 31, 2016 $ 298,701 $ 122,258 4,279 $ (44,569)   $ 216,733    
Income (Loss) Attributable to Noncontrolling Interest $ 641   $ 641